Hydrogel Delivery of Extracellular Vesicles to Treat Osteoarthritis
水凝胶递送细胞外囊泡治疗骨关节炎
基本信息
- 批准号:10631851
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdrenal Cortex HormonesAdultAffectAffinityAgingAnimal ModelAreaArticular Range of MotionAwardBehaviorBiomedical EngineeringCartilageCellsClinicClinicalCollaborationsCustomDataDefectDegenerative polyarthritisDevelopmentDiffusionDiseaseDisease ProgressionEncapsulatedEngineeringEngraftmentEnsureEvaluationFDA approvedFamily suidaeFormulationGelGenetic MaterialsGoalsGrowth FactorHistologyHyaluronic AcidHydrogelsIn SituIn VitroIncidenceInflammationInjectableInjection of therapeutic agentInjectionsInjuryInvestigationJointsKineticsLabelLeadMagnetic Resonance ImagingMeasuresMechanicsMediator of activation proteinMiniature SwineModelingMonitorMotionMotivationNon-Steroidal Anti-Inflammatory AgentsOrthopedicsPainPain-FreeParacrine CommunicationPatientsPolymersProcessPropertyProtease InhibitorProteinsRegenerative MedicineSourceStructureSurfaceSurface PropertiesSurgeonSymptomsSyringesSystemTechniquesTherapeuticThinnessTimeTissue EngineeringTissuesTranslatingTraumatic injuryVeteransWaterWorkarticular cartilageassociated symptombasebiomaterial developmentcartilage degradationclinical applicationclinically relevantcrosslinkdensitydisabilityefficacy testingexperienceextracellular vesiclesfunctional outcomeshealingin vivointerestknee replacement arthroplastymechanical forcemesenchymal stromal cellmilitary veterannew technologynovelnovel therapeuticsparacrinereconstructionrepair strategystem cell deliverysymptom treatmenttranslational model
项目摘要
Articular cartilage has limited intrinsic healing capacity, and as a result, any injury, as well as
the natural aging process, may lead to osteoarthritis (OA). Various reconstructive techniques
are being employed for treatment of focal defects; however, there are few approaches
being developed to address damage across cartilage surfaces with OA and to alter the
progression of the disease. Although there are therapeutic molecules that may be of interest to
treat OA, their systemic application is limited due to off-target concerns and local injection has
limited efficacy due to short half-lives. To address these concerns, injectable hydrogels may be
used to locally delivery and sustain the release of therapeutics to the joint. The objective of
this study is to develop an injectable hydrogel for the delivery of therapeutic extracellular
vesicles (EVs) and to evaluate the EV/hydrogel therapy in a minipig model of OA. Two Aims
will be pursued towards this goal. In Aim 1 we will use our experience in biomaterial
development to engineer a shear-thinning and self-healing hydrogel based on hyaluronic acid
(HA). We will use dynamic covalent crosslinks to obtain these desired properties and will
encapsulate and release EVs isolated from pig mesenchymal stromal cells (MSCs). The MSC
EVs will be characterized for size, surface properties, and content before and after release
and the release kinetics will be monitored with fluorescent labeling from hydrogels with a range
of crosslink densities. This Aim will identify one hydrogel formulation that releases EVs over
several weeks that can be used for in vivo assessment in Aim 2. In Aim 2 we will test the
efficacy of our engineered hydrogel therapies in an in vivo setting. Using our Yucatan minipig
model of OA, we will evaluate functional outcomes (histology, MRI) after injection of our
hydrogels containing EVs. This evaluation will include activity measures (steps/day) and
joint range of motion using custom motion tracking systems that we previously developed.
Upon completion, we will have developed an injectable hydrogel therapeutic that is applied
through a simple process similar to viscosupplements to deliver therapeutics to alter the
progression of disease with OA. This therapy could be translated to the clinic for treatment of
the large number of OA patients in the Veteran population who have few treatment options
and could limit the number of total knee replacements performed.
关节软骨的内在愈合能力有限,因此任何损伤以及
自然衰老过程,可能导致骨关节炎(OA)。各种重建技术
用于治疗局灶性缺陷;然而,方法很少
正在开发用于解决 OA 软骨表面损伤并改变
疾病的进展。尽管有一些治疗分子可能会引起人们的兴趣
治疗 OA,由于脱靶问题和局部注射,其全身应用受到限制
由于半衰期短,疗效有限。为了解决这些问题,可注射水凝胶可能是
用于局部输送和维持治疗药物向关节的释放。的目标
这项研究旨在开发一种可注射水凝胶,用于输送治疗性细胞外药物
囊泡 (EV) 并评估 EV/水凝胶疗法在小型猪 OA 模型中的作用。两个目标
将朝着这个目标不断努力。在目标 1 中,我们将利用我们在生物材料方面的经验
开发基于透明质酸的剪切稀化和自修复水凝胶
(哈)。我们将使用动态共价交联来获得这些所需的特性,并将
封装并释放从猪间充质基质细胞 (MSC) 中分离的 EV。 MSC
电动汽车在发布前后将对其尺寸、表面特性和含量进行表征
释放动力学将通过水凝胶的荧光标记进行监测
交联密度。该目标将确定一种水凝胶配方,可在超过
几周的时间可用于目标 2 中的体内评估。在目标 2 中,我们将测试
我们的工程水凝胶疗法在体内环境中的功效。使用我们的尤卡坦迷你猪
OA 模型,我们将在注射我们的药物后评估功能结果(组织学、MRI)
含有 EV 的水凝胶。该评估将包括活动测量(步数/天)和
使用我们之前开发的定制运动跟踪系统的关节运动范围。
完成后,我们将开发出一种可注射的水凝胶疗法,可应用于
通过类似于粘稠补充剂的简单过程来提供治疗以改变
OA 疾病的进展。这种疗法可以转化为临床治疗
退伍军人群体中大量 OA 患者几乎没有治疗选择
并且可能会限制膝关节置换术的总数量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert L Mauck其他文献
Robert L Mauck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert L Mauck', 18)}}的其他基金
Activation of endogenous progenitors via a nanoparticle-conjugated fibrous system to enhance meniscus repair
通过纳米颗粒共轭纤维系统激活内源祖细胞以增强半月板修复
- 批准号:
10607306 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral Implants
使用解剖组织工程骨软骨植入物进行膝关节表面置换
- 批准号:
10704534 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral Implants
使用解剖组织工程骨软骨植入物进行膝关节表面置换
- 批准号:
10248368 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Hydrogel Delivery of Extracellular Vesicles to Treat Osteoarthritis
水凝胶递送细胞外囊泡治疗骨关节炎
- 批准号:
10176189 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral Implants
使用解剖组织工程骨软骨植入物进行膝关节表面置换
- 批准号:
10454898 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Mechanobiology of Progenitor Cells in Heterotopic Ossification
异位骨化中祖细胞的力学生物学
- 批准号:
10401824 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Mechanobiology of Progenitor Cells in Heterotopic Ossification
异位骨化中祖细胞的力学生物学
- 批准号:
9926811 - 财政年份:2018
- 资助金额:
-- - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
-- - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant